Success Stories: EB-1A Approved for Investigator in China in the Field of Medical Virology
On December 15th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for an Investigator in the Field of Medical Virology (Approval Notice)
Position at the Time of Case Filing: Investigator
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: China
Approval Notice Date: December 15th, 2014
Processing Time: 6 Months, 11 Days
In this case, the client that we had the opportunity to work with was an Investigator from China in the field of Medical Virology. His specialized research has focused on the role of DNA epigenetics in relation to host immune response, the molecular processes inherent to diseases such as HIV, and proinflammatory factor effects in relation to influenza. His work had resulted in 12 peer-reviewed scientific articles, one recently accepted manuscript, numerous presentations at national and international conferences, and one pending patent; at the time that his case was filed, his publications had been cited at least 231 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 14 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client’s] research is the first to connect the ATP-dependent chromatin remodel complex with cardiovascular development. This has broadened our knowledge of the human genome and provided important genetic information that helps us understand the mechanisms behind a wide variety of human developmental diseases. This allows for the diagnosis and treatment of heart diseases.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Medical Virology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 6 months and 11 days.